India · Delayed Price · Currency is INR Alivus Life Sciences Statistics
Total Valuation
BOM:543322 has a market cap or net worth of INR 112.89 billion. The enterprise value is 106.97 billion.
| Market Cap | 112.89B |
| Enterprise Value | 106.97B |
Important Dates
The last earnings date was Thursday, January 22, 2026.
| Earnings Date | Jan 22, 2026 |
| Ex-Dividend Date | Sep 1, 2025 |
Share Statistics
| Current Share Class | 122.74M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 10.10% |
| Float | 30.84M |
Valuation Ratios
The trailing PE ratio is 20.76 and the forward PE ratio is 16.80.
| PE Ratio | 20.76 |
| Forward PE | 16.80 |
| PS Ratio | 4.49 |
| PB Ratio | 3.74 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.67 |
| EV / Sales | 4.26 |
| EV / EBITDA | 13.78 |
| EV / EBIT | 15.03 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | n/a |
| Interest Coverage | 133.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 21.98% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 11.40M |
| Profits Per Employee | 2.47M |
| Employee Count | 2,203 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543322 has paid 1.83 billion in taxes.
| Income Tax | 1.83B |
| Effective Tax Rate | 25.19% |
Stock Price Statistics
The stock price has decreased by -11.03% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.03% |
| 50-Day Moving Average | 903.91 |
| 200-Day Moving Average | 965.40 |
| Relative Strength Index (RSI) | 51.10 |
| Average Volume (20 Days) | 4,136 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543322 had revenue of INR 25.12 billion and earned 5.44 billion in profits. Earnings per share was 44.23.
| Revenue | 25.12B |
| Gross Profit | 13.84B |
| Operating Income | 7.12B |
| Pretax Income | 7.27B |
| Net Income | 5.44B |
| EBITDA | 7.73B |
| EBIT | 7.12B |
| Earnings Per Share (EPS) | 44.23 |
Balance Sheet
The company has 6.53 billion in cash and 604.45 million in debt, with a net cash position of 5.92 billion.
| Cash & Cash Equivalents | 6.53B |
| Total Debt | 604.45M |
| Net Cash | 5.92B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 30.15B |
| Book Value Per Share | 245.82 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 55.09%, with operating and profit margins of 28.34% and 21.64%.
| Gross Margin | 55.09% |
| Operating Margin | 28.34% |
| Pretax Margin | 28.93% |
| Profit Margin | 21.64% |
| EBITDA Margin | 30.76% |
| EBIT Margin | 28.34% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.54%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.54% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.52% |
| Earnings Yield | 4.82% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |